TickerRisk
Learn Pricing Open Scanner

Zoetis Inc. (ZTS) Options Risk Score

Real-time risk analysis for ZTS options traders — updated every 30 minutes.

100
HIGH Risk
51.6
IV Rank
49.8%
IV %
2026-08-06
Next Earnings
Pharmaceutical Preparations
Sector

Data last updated: 2026-07-23

Run a full ZTS options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.


Scan ZTS Now — Free →

Is it risky to sell options on Zoetis Inc. (ZTS) right now?

Zoetis Inc. (ZTS) currently scores 100 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. That score is driven by an upcoming earnings report, 10 recent news items and 4 active legal filings falling inside the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on ZTS is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.

ZTS shows an IV Rank of 52, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 50%. IV Rank is the most useful figure for deciding whether to sell or buy premium on ZTS.

ZTS reports on 2026-08-06. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer